Skin Diseases, Genetic D012873

Diseases [C] » Skin and Connective Tissue Diseases [C17] » Skin Diseases » Skin Diseases, Genetic

Description

Diseases of the skin with a genetic component, usually the result of various inborn errors of metabolism.   MeSH

Subtype Terms (32)

Albinism
6 drugs (4 approved, 2 experimental)

Cutis Laxa
1 experimental drug

Darier Disease
1 approved drug

Dermatitis, Atopic
346 drugs (103 approved, 243 experimental)

Dyskeratosis Congenita
12 drugs (11 approved, 1 experimental)

Ectodermal Dysplasia
 

Ehlers-Danlos Syndrome
6 drugs (5 approved, 1 experimental)

Epidermolysis Bullosa
47 drugs (19 approved, 28 experimental)

Erythrokeratodermia Variabilis
 

Hereditary Autoinflammatory Diseases
4 drugs (3 approved, 1 experimental)

Hyalinosis, Systemic
 


Phase 3 Indicated Drugs (3)


Organization Involved with Phase 3 Indications (4)

Organization Involved with Phase 2 Indications (3)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.